Preventive Misconception as a Motivation for Participation and Adherence in Microbicide Trials: Evidence from Female Participants and Male Partners in Malawi and Zimbabwe
- 24 August 2011
- journal article
- research article
- Published by Springer Nature in AIDS and Behavior
- Vol. 16 (3) , 785-790
Abstract
This paper presents empirical data on motivation to join an HIV prevention trial of vaginal microbicide gels in Malawi and Zimbabwe, and participant assumption of a preventive misconception. Interviews were conducted with women participating in the trial and their male partners. Most of the female participants were able to adequately describe basic aspects of the trial design. HIV counseling and testing were primary reasons motivating women’s participation, and male partners’ support of the trial. 29% of women and 20% of men also provided indications of a preventive misconception, attributing gel use and trial participation to avoiding HIV infection.Keywords
This publication has 10 references indexed in Scilit:
- Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in womenAIDS, 2011
- Blockage and flow: intimate experiences of condoms and microbicides in a South African clinical trialCulture, Health & Sexuality, 2010
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and IndiaCulture, Health & Sexuality, 2010
- Preventive MisconceptionAmerican Journal of Preventive Medicine, 2007
- Male Circumcision in Siaya and Bondo Districts, KenyaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- “We Have Our Protector”: Misperceptions of Protection Against HIV Among Participants in a Microbicide Efficacy TrialAmerican Journal of Public Health, 2006
- Undue inducement in clinical research in developing countries: is it a worry?The Lancet, 2005
- Increase in Sexual Risk Behavior Associated with Immunologic Response to Highly Active Antiretroviral Therapy among HIV‐Infected Injection Drug UsersClinical Infectious Diseases, 2004
- Shifts in condom use following microbicide introductionAIDS, 2003